Status:
UNKNOWN
A Randomized Controlled Trial of Acupuncture in Treating Migraine
Lead Sponsor:
The Third Affiliated hospital of Zhejiang Chinese Medical University
Conditions:
Migraine Without Aura
Eligibility:
All Genders
25-50 years
Phase:
NA
Brief Summary
Migraine without aura is a common kind of nervous system diseases that can easily cause recurrent headache, leading to severe impacts on quality of life and health care costs. Current therapeutic opti...
Detailed Description
This randomized controlled trial will enroll 96 migraine patients without aura from the Third Affiliated Hospital of Zhejiang Chinese Medical University. All patients will be randomly assigned to eith...
Eligibility Criteria
Inclusion
- Patients meet the diagnostic criteria of migraine without aura;
- 25 ≤ age ≤50 years, male or female;
- The efficacy of drugs and other therapeutic methods is not obvious; the frequency of migraine attacks in the past 3 months is more than twice a month;
- Drug treatment for migraine without aura is stopped for at least one week;
- Participants can understand the study protocol and written informed consent is signed.
Exclusion
- Patients have severe complications in cardiovascular, liver, kidney, hematopoietic and other systems;
- Pregnant or lactating women;
- Patients have spontaneous bleeding tendency so it is not suitable for them to receive acupuncture;
- Patients have an allergic history of flunarizine hydrochloride or a history of depression;
- Patients are diagnosed as psychosis.
Key Trial Info
Start Date :
April 21 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2023
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT04766762
Start Date
April 21 2021
End Date
February 28 2023
Last Update
July 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Third Affiliated Hospital of Zhejiang Chinese Medical University
Hangzhou, Zhejiang, China, 310000